637 related articles for article (PubMed ID: 21911714)
1. Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
Pawlik TM; Reyes DK; Cosgrove D; Kamel IR; Bhagat N; Geschwind JF
J Clin Oncol; 2011 Oct; 29(30):3960-7. PubMed ID: 21911714
[TBL] [